New license agreement with Orion Corporation
2008-03-26
Interim report May 2007 - Jan 2008
2008-03-14
Phase III results presented in Copenhagen
2008-03-03
Oasmia presents Phase III-results in Denmark
2008-01-31
Final advice for Paclical Phase III program
2008-01-29
Oasmia announces licensing agreement
2007-11-27
Oasmia presented in Florida
2007-11-05
Oasmia presents in USA
2007-10-09
Oasmia in Barcelona
2007-09-27
Great interest for Oasmia in Budapest
2007-09-20
Oasmia to NGM Equity
2007-09-17
Oasmia publishes Listing Prospectus
2007-09-17
Oasmia presents in Budapest
2007-06-19
“Jackpot in sight for Oasmia”
2007-06-07
Status – listing of Oasmia
2007-05-29
Very good clinical results for Paclical®
2007-04-16
Unique results for cancer drug
2007-03-27
New drug for treatment of cancer in dog
2007-03-13
OASMIA confirms Orphan Drug Designation
2006-11-30
Oasmia obtains Orphan Drug designation
2006-11-15
Interim report 2006-10-31
2006-10-31